Connect with us

Press Release

“Data Island” Problem Can Be Solved by Combining Privacy Computing AI and Blockchain Technology

Published

5 years ago

on

Platon Now Offers Breakthrough Solutions to Break the “Data Island” and Release the Value Potential

During the COVID-19 pandemic, medical networking services developed rapidly, and big data played a key role in the development. In the medical industry, new medical models and cutting-edge research also require a large number of patient data to verify. However, due to the lack of effective privacy protection, data cannot be shared, resulting in the “data island” phenomenon, which has become a big problem to be solved. At the same time, the widespread use of medical big data also triggered the issue of privacy leaks and data abuse, and raised social concerns about data security and privacy protection.

These problems exist not only in the medical industry, but also in other industries. Citing the protection of trade secrets and refusing to trade their own data, government departments are also reluctant to share data because of security, interests, technology, and other concerns. This exacerbates the “data Island” problem, which restricts the maximization of data value.

In the current data market, users produce new online data every day, but they do not own the data. Data is held in the hands of each independent collector, resulting in the compartmentalization of data ownership, which is referred to as “data Island.” The lack of data privacy protection and sharing mechanism is the main obstacle for data authentication.

Blockchain provides an opportunity for data validation. Blockchain is a distributed ledger technology designed to realize transaction accounting through the joint participation of multi-nodes, and each node account is complete and cannot be tampered with. This helps in integrating users into the three-party governing account for insusceptible and uninterrupted data production, data monopoly and data use.

Through node authorization, the final data income is shared among the parties in proportion to realizing the sharing of data ownership. Although transaction information is shared in this process, account information is highly encrypted. Therefore, zero-knowledge proof is an effective strategy to protect the privacy of accounts. Zero-knowledge proof is to make the verifier believe that he has certain knowledge or ability without providing any useful information to the verifier, for example, to realize the asset transfer without disclosing user identity.

Blockchain technology can be widely used in equipment authentication, communication encryption and other areas to provide a strong support for breaking the “data island” and promoting data transactions.

Privacy computing brings solutions

The realization of data sharing transaction and potential value release happens on the value chain of “property right confirmation – privacy protection – co-computing – value sharing.” The scheme, which is widely accepted by finance and blockchain industry, is based on the solution combining privacy computing and AI, which is a new way to solve security problems such as key management, by integrating multiple cryptography algorithms with frontier blockchain technology. Public chain PlatOn is the pioneer that set a precedence of multi-party secure computing (MPC) and other cryptographic algorithms into the key management system (KMS), which realizes the management of massive scale digital assets through cryptography, thereby effectively resolving the contradiction between data privacy protection, right ownership and data sharing, and improving the value and efficiency of data. The technology can be used in future scenarios such as digital wallets and inter-agency transactions.

PlatON has focused on the combination of privacy computing and big data AI. The open-sourced, community-based, blockchain ecosystem recently launched Tensorflow, the world’s first privacy AI framework that supports mainstream in-depth learning. PlatON’s series of innovative practices have provided an observable way to solve the problem of “data island” and data asset transaction.

Thanks to its rich industry experience, PlatON can fix the impasse and step forward. It is reported that PlatON’s core founding team has more than 15 years of experience in finance and communications, and strong software implementation capability too. These are exactly what the foundation for PlatON is built on to continuously and effectively promote R&D investment and business practice. At present, PlatON is focusing on R&D and solving the problem of data sharing step by step in the engineering and business world. Currently, PlatON’s leading network, Alaya, is focused on the financial sector, where data is highly standardized and financial institutions have a strong desire to address data privacy concerns.

PlatON’s Future Vision: Building a Data Transaction Infrastructure

PlatON has become a global leader in the field of privacy-protected computing. With the accumulation of finance and AI, PlatON has reached strategic cooperation with HashQuark, Keystore, HashKey Hub and other well-known platforms in the industry to jointly promote the implementation and application of cutting-edge technologies, such as KeyShard, so as to realize the new digital assets custody service in the world and better protect the security of digital assets.

PlatON’s vision is to build a peer-to-peer computing network that integrates verifiable computing, privacy computing, scalable computing, and dedicated computing hardware to provide open-source public infrastructure software development, consulting, and operational services to developers, data providers, as well as various communities, organizations, and individuals with computing needs around the world, and ultimately to support mass data asset transactions.

About Author

Alex Jacob

Alex Jacob is a literature author. He was born in Chicago. Alex passion is writing news articles. He writes number of articles and published it.

See author's posts

Disclaimer: The views, suggestions, and opinions expressed here are the sole responsibility of the experts. No Digi Observer journalist was involved in the writing and production of this article.

Related Topics:
Continue Reading

Press Release

Gastro Center of Maryland Expands Footprint, Bringing Expert Digestive Care to More Communities Across the DMV

Published

2 hours ago

on

December 1, 2025

By

Gastro Center of Maryland (GCM), one of the state’s largest GI practices, announces expansion to serve more patients across the DMV. With locations in Annapolis, Bethesda, Columbia, Gaithersburg, Olney, Riverdale, Silver Spring, Timonium, and White Marsh, GCM offers comprehensive digestive care including colonoscopies, endoscopies, and advanced treatments. State-of-the-art facilities feature onsite pathology and an IBD Infusion Center. Same-week and NextDay appointments available. Now welcoming new patients.

Silver Spring, Maryland, United States, 1st Dec 2025 – Gastro Center of Maryland (GCM), one of the largest and most respected gastroenterology practices in the state, recently announced its continued expansion with the addition of Silver Spring and Bethesda Location. This strategic growth reinforces the organization’s commitment to delivering expert, compassionate digestive care closer to home for patients throughout Maryland and the greater DMV region.

With this expansion, Gastro Center of Maryland now operates 9 locations across the state, including Annapolis, Bethesda, Columbia, Gaithersburg, Olney, Riverdale, Silver Spring, Timonium/Lutherville, and White Marsh. The practice’s growth comes in direct response to increasing demand for specialized gastroenterological services as digestive health conditions continue to rise nationwide.

“Our mission has always been to provide exceptional, patient-centered digestive care to every community we serve,” said Sarah, an employee. “This expansion allows us to bring our expertise, advanced technology, and compassionate approach to even more patients who deserve convenient access to world-class gastroenterology services.”

Gastro Center of Maryland specializes in diagnosing and treating a comprehensive range of digestive and liver conditions, including acid reflux, irritable bowel syndrome (IBS), Crohn’s disease, ulcerative colitis, hepatitis, fatty liver disease, and colon cancer. The practice operates state-of-the-art Ambulatory Surgery Centers equipped with the latest medical technology, offering advanced procedures such as Bravo pH testing, PillCam capsule endoscopy, STRETTA for reflux treatment, and the Orbera gastric balloon system for weight loss.

Patients benefit from GCM’s integrated care model, which includes onsite pathology services and an IBD Infusion Center for faster, more accurate diagnoses and treatments. The practice also offers same-week and NextDay GI appointments, ensuring patients receive timely care when they need it most.

Gastro Center of Maryland accepts most major insurance plans, including private insurance, federally sponsored plans, and covered Maryland plans. New patients are welcome and can schedule appointments by calling (410) 290-6677 or visiting www.gastromaryland.com.

Media Contact

Organization: Gastro Center of Maryland

Contact Person: Daniel Dent

Website: https://www.gastromaryland.com/

Email:
christiang@gastrocenter.com

Contact Number: +14102906677

Address:10301 Georgia Ave #208

City: Silver Spring

State: Maryland

Country:United States

Release id:38186

The post Gastro Center of Maryland Expands Footprint, Bringing Expert Digestive Care to More Communities Across the DMV appeared first on King Newswire. This content is provided by a third-party source.. King Newswire makes no warranties or representations in connection with it. King Newswire is a press release distribution agency and does not endorse or verify the claims made in this release. If you have any complaints or copyright concerns related to this article, please contact the company listed in the ‘Media Contact’ section

file

About Author

Cloud PR Wire

See author's posts

Disclaimer: The views, suggestions, and opinions expressed here are the sole responsibility of the experts. No Digi Observer journalist was involved in the writing and production of this article.

Continue Reading

Press Release

New Digital Philanthropy Initiative Launched at Asia Philanthropy Forum in Boao

Published

2 hours ago

on

December 1, 2025

By

In a significant move to harness technology for social good, the ECI@Charity Digital Philanthropy Innovation Committee was officially launched today at the Asia Philanthropy Forum in Boao. The establishment of this global platform marks a strategic evolution for ECI, positioning it from an innovation observer to a proactive builder in the philanthropic sector, leveraging the unique opportunities presented by the Hainan Free Trade Port.

Under the theme “Open Collaboration, Innovative Development,” the Forum gathered over 600 delegates from 16 countries and regions, including government officials, heads of international organizations, philanthropists, and leading entrepreneurs. The event was organized by the Hainan Asia Philanthropy Research Institute under the guidance of the China NGO Network for International Exchanges.

A First-of-its-Kind Global Platform

The ECI@Charity Committee stands as the world’s first cross-border platform dedicated to channeling digital innovation toward improving the lives and well-being of persons with disabilities. Its mission is to foster a more inclusive and caring digital society, enabling individuals with disabilities to achieve greater health, happiness, and dignity through technological empowerment.

Dr. Owen Jia, Global Initiator of ECI, addressed the Asian Philanthropy Forum on “ Powering Good with Digital, Reshaping Giving with Innovation “.

“We are bringing technological innovation back to its humanistic roots,” said Dr. Owen Jia, Global Initiator of the ECI Awards. “By focusing on fundamental human needs, we embark on a new journey of ‘Innovation for Good.’ This committee represents a concrete step toward our vision of serving as a ‘Nobel Prize for the innovation field.’”

Dr. Owen Jia (left), Global Initiator of ECI Awards, and Mr. Shouzhen Xu (right), Co-Chairman of Asian Philanthropy Forum and Executive Chairman of ECI@Charity.

To lead this initiative, Dr. Jia has appointed Mr. Xu Shouzhen as the Executive Chairman of ECI@Charity. Mr. Xu, who also serves as Co-Chairman of the Boao Forum for Asian Philanthropy, will spearhead efforts to consolidate top-tier global innovation resources. “Our goal is to build a transformative collaboration platform that delivers practical, tech-driven solutions in areas like digital healthcare and accessible entertainment,” stated Mr. Xu.

Four-Pillar Action Framework

The Committee will drive impact through four core initiatives:

1. Research & Insights: Publishing an annual “White Paper on Digital Life Needs and Technological Innovation for Persons with Disabilities.”

2. Connection & Co-creation: Hosting the “ECI@Charity Tech for Good Innovation Summit” and “Tech for Disability Innovation Marathon.”

3. Catalyzation & Implementation: Establishing an “ECI@Charity Seed Fund” and a curated “Solutions Resource Library.”

4. Recognition & Promotion: Integrating the specialized “ECI@Charity Awards” into the esteemed ECI Awards framework to benchmark excellence.

First Wave of Initiative Projects Launched

Concurrently, the Committee launched three initiative projects: the “Digital Healing” Partnership Program, connecting digital health enterprises with rehabilitation institutions; the “Accessible Gaming” Developers Alliance, formulating and promoting accessible game design standards; and the “Heartvoice Connect” Public Welfare Communication project, utilizing digital technologies to showcase the talents of artists with disabilities.

Launch Projects and Strategic Support

The Committee announced three flagship partnership programs at launch:

· The “Digital Healing” Partnership Program, linking digital health enterprises with rehabilitation institutions.

· The “Accessible Gaming” Developers Alliance, to formulate and promote inclusive game design standards.

· The “Heartvoice Connect” Public Welfare Communication project, using digital tools to amplify the talents of artists with disabilities.

Mr. James George, Deputy Resident Representative of the United Nations Development Programme (UNDP) in China, delivered a speech at the opening ceremony of the Asian Philanthropy Forum.

The initiative received notable support from the international community. Mr. James George, Deputy Resident Representative of the United Nations Development Programme (UNDP) in China, addressed the Forum, underscoring the importance of multi-stakeholder partnerships in achieving sustainable development goals.

2025 Asian Philanthropy Forum

Looking Ahead

Positioned at the new frontier of digital civilization, ECI@Charity will utilize the open policy framework of the Hainan Free Trade Port to aggregate global innovators. It aims to contribute substantively to a more equitable, inclusive, and compassionate digital future, solidifying its transition from an innovation observer to a definitive leader in shaping that future.

About ECI Awards

The ECI Awards (International Awards for Innovation in Business and Marketing), organized by the International Entrepreneurs, Creatives & Innovators Association (IECIA), is a globally recognized accolade celebrating innovation that creates new market value. It honors achievements across business models, products, services, technology, marketing, and social innovation.

Media Contact

Organization: Secretary General of EClAwards Committee

Contact Person: Faye Feng

Website: https://www.eciawards.org.cn

Email: Send Email

City: BOAO

Country:China

Release id:38261

The post New Digital Philanthropy Initiative Launched at Asia Philanthropy Forum in Boao appeared first on King Newswire. This content is provided by a third-party source.. King Newswire makes no warranties or representations in connection with it. King Newswire is a press release distribution agency and does not endorse or verify the claims made in this release. If you have any complaints or copyright concerns related to this article, please contact the company listed in the ‘Media Contact’ section

file

About Author

Cloud PR Wire

See author's posts

Disclaimer: The views, suggestions, and opinions expressed here are the sole responsibility of the experts. No Digi Observer journalist was involved in the writing and production of this article.

Continue Reading

Press Release

Santersus AG Completes Series A Financing and Announces Strategic Collaboration with Terumo Corporation

Published

2 hours ago

on

December 1, 2025

By

Santersus AG Announces Advancement of NucleoCapture into Pivotal Clinical Development strengthened by Strategic Collaboration with Terumo

Zurich, Switzerland, 1st Dec 2025 – Santersus AG today announced the successful completion of its Series A financing, led by Norcliffe, a UK life sciences fund with participation from Terumo Ventures. The financing will support the advancement of Santersus’ NucleoCapture into pivotal clinical development while accelerating progress across Santersus’ broader pipeline.

Santersus has entered a strategic collaboration with Terumo Blood and Cell Technologies to advance NucleoCapture(TM) for the treatment of sepsis, a disease that kills 11M people worldwide each year. The collaboration integrates Santersus’ first-in-class NucleoCapture blood purification device with Terumo BCT’s industry-leading Spectra Optia Apheresis System, creating a novel therapeutic apheresis approach designed to selectively remove neutrophil extracellular traps (NETs)— a major contributor to systemic inflammation and sepsis-related organ dysfunction. NucleoCapture has previously been granted two U.S. FDA Breakthrough Device Designations, including one for the treatment of sepsis.

Under this collaboration, Santersus will lead the pivotal NUC-CAP clinical trial across the United States, United Kingdom, Switzerland and Europe. Terumo BCT will support the clinical development of the program, and Terumo Ventures – the corporate VC arm of Terumo – has invested in Santersus’ Series A financing round to accelerate the development of this technology for a critical unmet need with high mortality.

“Therapeutic apheresis has untapped potential to address serious unmet medical needs,” said Veerle d’Haenens, General Manager of Global Therapy Innovations at Terumo Blood and Cell Technologies. “Our partnership with Santersus reflects our commitment to advancing innovative treatment options for critically ill patients.”

The Series A financing will also support Santersus’ preparation for pivotal clinical trials in systemic lupus erythematosus (SLE), where NucleoCapture has received its second U.S. FDA Breakthrough Device Designation for treatment-refractory disease. The pivotal SLE program addressing an estimated $4bn global treatment market – will expand Santersus’ late-stage clinical portfolio beyond critical care and is expected to begin following the sepsis study launch.

Santersus is also advancing NucleoCapture technology into solid-organ transplantation, including a program designed to perfuse and recondition heavily damaged donor livers prior to transplantation. The global organ transplantation market is projected to reach $61.5bn by 2027. In parallel, Santersus is expanding a NucleoCapture program in lung transplantation focused on the prevention of primary graft dysfunction (PGD). Together, these initiatives support the application of NucleoCapture across solid-organ transplantation.

Santersus is also advancing early-stage development of NucleoCapture for Alzheimer’s disease, with an exploratory clinical study under way to assess its effects on amyloid removal. The global Alzheimer’s therapeutics market is valued at approximately $5bn in 2025 and is projected to double over the next decade.

These integrated programs reflect Santersus’ transition towards a multi-indication, late-stage clinical development company and position Santersus as a leading developer of NETs-targeted therapeutic apheresis technologies across critical care, autoimmunity, solid-organ transplantation, and neurodegeneration.

About Santersus AG

Zurich-based Santersus AG is a biotechnology company developing NucleoCapture, a novel, patent-protected extracorporeal blood purification technology designed to selectively remove cell-free DNA (cfDNA) and neutrophil extracellular traps (NETs). NucleoCapture has received two U.S. FDA Breakthrough Device Designations: one for the treatment of sepsis and one for systemic lupus erythematosus. Santersus is advancing a diversified clinical pipeline across sepsis, systemic lupus erythematosus, solid-organ transplantation (liver and lung), and Alzheimer’s disease.

For more information, please visit www.santersus.com

Media Contact

Organization: Santersus AG

Contact Person: Aleksander Zaporoztsev

Website: https://www.santersus.com

Email:
info@santersus.com

Country:Switzerland

Release id:38172

The post Santersus AG Completes Series A Financing and Announces Strategic Collaboration with Terumo Corporation appeared first on King Newswire. This content is provided by a third-party source.. King Newswire makes no warranties or representations in connection with it. King Newswire is a press release distribution agency and does not endorse or verify the claims made in this release. If you have any complaints or copyright concerns related to this article, please contact the company listed in the ‘Media Contact’ section

file

About Author

Cloud PR Wire

See author's posts

Disclaimer: The views, suggestions, and opinions expressed here are the sole responsibility of the experts. No Digi Observer journalist was involved in the writing and production of this article.

Continue Reading

LATEST POST

Like Us
Follow Us
Subscribe Us
Follow Us